Urology Doctors in Port Charlotte, FL Accepting Medicare

4 Urology doctors found. Showing 1 - 4

Marc A Melser, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3410 Tamiami Trl, Suite 4, Port Charlotte, FL 33952 Phone: 941-235-7281    Fax: 941-235-0463

Jens C. Carlsen, DO Urology Medicare: Accepting Medicare Assignments Practice Location: 2525 Harbor Blvd Ste 301, Port Charlotte, FL 33952 Phone: 941-421-0756

Dr. Gary Lee Berger, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 2400 Harbor Blvd, Suite 21, Port Charlotte, FL 33952 Phone: 941-625-6992    Fax: 941-625-7238

Crystal Smedley, Urology Medicare: Accepting Medicare Assignments Practice Location: 2400 Harbor Blvd Ste 21, Port Charlotte, FL 33952 Phone: 941-625-6992

News Archive

Blocking BRAF ubiquitination may be an effective treatment approach in melanoma

The protein BRAF is a key player in the development of many different types of cancer, including melanoma.

Mithridion secures commitments of $1.25 million in new funding

Mithridion, Inc., a privately-owned clinical stage drug development company focusing on serious Central Nervous System disorders, including Alzheimer's disease, announces that it has secured commitments of $1.25 million in new funding.

Progressive resistance strength training for improving physical function in seniors

Progressive resistance strength training not only helps older adults become stronger but also makes their everyday life easier, a Cochrane Review suggests.

Caraco generates $40.4 million and $268.2 million in third quarter, first nine months of Fiscal Year 2011

Caraco Pharmaceutical Laboratories, Ltd. generated net sales of $40.4 million and $268.2 million in the third quarter and first nine months of its Fiscal Year 2011, respectively, as compared to $52.0 million and $178.4 million, respectively, for the corresponding periods of our previous fiscal year ended December 31, 2009.

New hepatitis C drugs to place economic burden on health care system, predicts MD Anderson study

The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country's health care system. The prediction comes from a cost-effectiveness analysis led by researchers at The University of Texas MD Anderson Cancer Center.

Read more Medical News

› Verified 5 days ago